ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.280,22
-0,96%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Karuna Therapeutics Inc (KRTX)

  7. Karuna Therapeutics Inc (KRTX) News

KRTX Karuna Therapeutics Inc

329,83
0,00 (0,00%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Karuna Therapeutics Inc KRTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 329,83 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
329,83 329,83
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.3.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202423:01EDGAR2Form 144 - Report of proposed sale of securities
01.3.202412:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01.3.202412:01EDGAR2Form 8-K - Current report
22.2.202412:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202412:32EDGAR2Form 8-K - Current report
22.2.202412:30BWKaruna Therapeutics Reports Fourth Quarter and Full Year..
15.2.202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12.2.202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202417:56EDGAR2Form 144 - Report of proposed sale of securities
05.2.202422:12EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22.1.202412:05EDGAR2Form PREM14A - Preliminary proxy statements relating to..
16.1.202422:18EDGAR2Form 8-K - Current report
09.1.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:18EDGAR2Form 144 - Report of proposed sale of securities
08.1.202416:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
29.12.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202323:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202323:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202323:07EDGAR2Form 8-K - Current report
22.12.202322:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202322:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202322:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202321:30PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
22.12.202317:15DJNTrending: Bristol Myers to Buy Karuna Therapeutics for $14..
22.12.202314:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.12.202314:26EDGAR2Form 8-K - Current report
22.12.202313:05BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
22.12.202312:59BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
15.12.202300:30BWKaruna Therapeutics Announces The Lancet Publication of Data..
12.12.202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202321:24EDGAR2Form 144 - Report of proposed sale of securities
29.11.202316:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
29.11.202313:13DJNKaruna Therapeutics Gets FDA Acceptance for KarXT NDA
29.11.202312:30BWKaruna Therapeutics Announces U.S. Food and Drug..
16.11.202322:01BWKaruna Therapeutics Announces Positive Results from Phase 1b..
13.11.202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202322:25EDGAR2Form 144 - Report of proposed sale of securities
02.11.202311:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202311:36EDGAR2Form 8-K - Current report
02.11.202311:30BWKaruna Therapeutics Reports Third Quarter 2023 Financial..
01.11.202311:45BWKaruna Therapeutics to Present Data from the EMERGENT..
01.11.202311:30BWKaruna Therapeutics to Present at Upcoming Investor..
19.10.202312:30BWKaruna Therapeutics to Announce Third Quarter 2023 Financial..
10.10.202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
KRTX
Karuna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten